230 related articles for article (PubMed ID: 10082469)
1. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
[TBL] [Abstract][Full Text] [Related]
2. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
[TBL] [Abstract][Full Text] [Related]
3. CD and NMR studies of prion protein (PrP) helix 1. Novel implications for its role in the PrPC-->PrPSc conversion process.
Ziegler J; Sticht H; Marx UC; Müller W; Rösch P; Schwarzinger S
J Biol Chem; 2003 Dec; 278(50):50175-81. PubMed ID: 12952977
[TBL] [Abstract][Full Text] [Related]
4. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
5. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
[TBL] [Abstract][Full Text] [Related]
6. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
7. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
[TBL] [Abstract][Full Text] [Related]
8. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
Hornemann S; Glockshuber R
J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
[TBL] [Abstract][Full Text] [Related]
9. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
10. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
11. Binding of prion proteins to lipid membranes.
Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
[TBL] [Abstract][Full Text] [Related]
12. Conformational properties of beta-PrP.
Hosszu LLP; Trevitt CR; Jones S; Batchelor M; Scott DJ; Jackson GS; Collinge J; Waltho JP; Clarke AR
J Biol Chem; 2009 Aug; 284(33):21981-21990. PubMed ID: 19369250
[TBL] [Abstract][Full Text] [Related]
13. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
14. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
[TBL] [Abstract][Full Text] [Related]
15. Scrapie prions: a three-dimensional model of an infectious fragment.
Huang Z; Prusiner SB; Cohen FE
Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
[TBL] [Abstract][Full Text] [Related]
16. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
[TBL] [Abstract][Full Text] [Related]
17. Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature.
Nandi PK; Bera A; Sizaret PY
J Mol Biol; 2006 Sep; 362(4):810-20. PubMed ID: 16949096
[TBL] [Abstract][Full Text] [Related]
18. Self-assembly of recombinant prion protein of 106 residues.
Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
[TBL] [Abstract][Full Text] [Related]
19. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
20. Multiple folding pathways for heterologously expressed human prion protein.
Jackson GS; Hill AF; Joseph C; Hosszu L; Power A; Waltho JP; Clarke AR; Collinge J
Biochim Biophys Acta; 1999 Apr; 1431(1):1-13. PubMed ID: 10209273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]